Publications

  1. Maran A, Dadsetan M, Buenz CM, Shogren KL, Lu L, Yaszemski MJ. Hydrogel-PLGA delivery system prolongs 2-methoxyestradiol-mediated anti-tumor effects in osteosarcoma cells. J Biomed Mater Res A. 2013 Sep; 101(9):2491-9. Epub 2013 Jan 27.
    View PubMed
  2. van der Deen M, Taipaleenmaki H, Zhang Y, Teplyuk NM, Gupta A, Cinghu S, Shogren K, Maran A, Yaszemski MJ, Ling L, Cool SM, Leong DT, Dierkes C, Zustin J, Salto-Tellez M, Ito Y, Bae SC, Zielenska M, Squire JA, Lian JB, Stein JL, Zambetti GP, Jones SN, MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. J Biol Chem. 2013 Jul 19; 288(29):21307-19. Epub 2013 May 29.
    View PubMed
  3. Yang C, Shogren KL, Goyal R, Bravo D, Yaszemski MJ, Maran A. RNA-dependent protein kinase is essential for 2-methoxyestradiol-induced autophagy in osteosarcoma cells. PLoS One. 2013; 8(3):e59406. Epub 2013 Mar 19.
    View PubMed
  4. Wang X, Krishnan C, Nguyen EP, Meyer KJ, Oliveira JL, Yang P, Yi ES, Erickson-Johnson MR, Yaszemski MJ, Maran A, Oliveira AM. Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor. Hum Pathol. 2012 Nov; 43(11):2047-52. Epub 2012 Jun 01.
    View PubMed
  5. Wimbauer F, Yang C, Shogren KL, Zhang M, Goyal R, Riester SM, Yaszemski MJ, Maran A. Regulation of interferon pathway in 2-methoxyestradiol-treated osteosarcoma cells. BMC Cancer. 2012; 12:93. Epub 2012 Mar 19.
    View PubMed
  6. Wang X, Asmann YW, Erickson-Johnson MR, Oliveira JL, Zhang H, Moura RD, Lazar AJ, Lev D, Bill K, Lloyd RV, Yaszemski MJ, Maran A, Oliveira AM. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma. Genes Chromosomes Cancer. 2011 Nov; 50(11):849-58. Epub 2011 Jul 26.
    View PubMed
  7. Demiralp B, Sarkar G, Okuno SH, Yaszemski MJ, Maran A. Osteosarcoma - an evaluation of current diagnosis, treatment and chemotherapy. European Musculoskeletal Review. 2011; 6(1):18-23.
  8. Kempen DH, Lu L, Hefferan TE, Creemers LB, Heijink A, Maran A, Dhert WJ, Yaszemski MJ. Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration. Tissue Eng Part A. 2010 Dec; 16(12):3769-77. Epub 2010 Sep 09.
    View PubMed
  9. Benedikt MB, Mahlum EW, Shogren KL, Subramaniam M, Spelsberg TC, Yaszemski MJ, Maran A. 2-methoxyestradiol-mediated anti-tumor effect increases osteoprotegerin expression in osteosarcoma cells. J Cell Biochem. 2010 Apr 1; 109(5):950-6.
    View PubMed
  10. Dadsetan M, Szatkowski JP, Shogren KL, Yaszemski MJ, Maran A. Hydrogel-mediated DNA delivery confers estrogenic response in nonresponsive osteoblast cells. J Biomed Mater Res A. 2009 Dec 15; 91(4):1170-7.
    View PubMed
  11. Halder C, Ossendorf C, Maran A, Yaszemski M, Bolander ME, Fuchs B, Sarkar G. Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma. Anticancer Res. 2009 Nov; 29(11):4317-22.
    View PubMed
  12. Yuan J, Ossendorf C, Szatkowski JP, Bronk JT, Maran A, Yaszemski M, Bolander ME, Sarkar G, Fuchs B. Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Invest. 2009 May; 27(4):435-42.
    View PubMed
  13. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials. 2009 May; 30(14):2816-25. Epub 2009 Feb 20.
    View PubMed
  14. Kempen DH, Yaszemski MJ, Heijink A, Hefferan TE, Creemers LB, Britson J, Maran A, Classic KL, Dhert WJ, Lu L. Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes. J Control Release. 2009 Mar 19; 134(3):169-76. Epub 2008 Dec 03.
    View PubMed
  15. Mandal D, Maran A, Yaszemski MJ, Bolander ME, Sarkar G. Cellular uptake of gold nanoparticles directly cross-linked with carrier peptides by osteosarcoma cells. J Mater Sci Mater Med. 2009 Jan; 20(1):347-50. Epub 2008 Sep 21.
    View PubMed
  16. Lowry MB, Lotinun S, Leontovich AA, Zhang M, Maran A, Shogren KL, Palama BK, Marley K, Iwaniec UT, Turner RT. Osteitis fibrosa is mediated by Platelet-Derived Growth Factor-A via a phosphoinositide 3-kinase-dependent signaling pathway in a rat model for chronic hyperparathyroidism. Endocrinology. 2008 Nov; 149(11):5735-46. Epub 2008 Jul 17.
    View PubMed
  17. Kempen DH, Lu L, Classic KL, Hefferan TE, Creemers LB, Maran A, Dhert WJ, Yaszemski MJ. Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants. J Control Release. 2008 Aug 25; 130(1):15-21. Epub 2008 May 13.
    View PubMed
  18. Maran A, Shogren KL, Benedikt M, Sarkar G, Turner RT, Yaszemski MJ. 2-methoxyestradiol-induced cell death in osteosarcoma cells is preceded by cell cycle arrest. J Cell Biochem. 2008 Aug 1; 104(5):1937-45.
    View PubMed
  19. Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Classic KL, Dhert WJ, Yaszemski MJ. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials. 2008 Aug; 29(22):3245-52. Epub 2008 May 09.
    View PubMed
  20. Heine-Geldern A, Dadsetan M, Benedikt M, Gaustad D, Herrick J, Shogren KL, Maran A, Hefferan TE, Yaszemski MJ. Effect of dynamic flow on hydrogel-mediated phenotypic expression of human osteoblasts. 8th World Biomaterials Congress 2008. 2008; 3:1359.
  21. Heine-Geldern A, Dadsetan M, Yaszemski A, Ozgo K, Maran A, Hefferan TE, Yaszemski MJ. Incorporation of hydroxyapatite into hydrogels enhances differentiation of osteoblasts. 8th World Biomaterials Congress 2008. 2008; 3:1360.
  22. Kempen DHR, Lu L, Heijink A, Hefferan TE, Creemers LC, Maran A, Yaszemski MJ, Dhert WJA. The effect of sequential VEGF and BMP-2 release on ectopic and orthotopic bone regeneration. 8th World Biomaterials Congress 2008. 2008; 1:312.
  23. Fuchs B, Mahlum E, Halder C, Maran A, Yaszemski M, Bode B, Bolander M, Sarkar G. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene. 2007 Sep 15; 399(2):137-43. Epub 2007 May 13.
    View PubMed
  24. Mahlum E, Mandal D, Halder C, Maran A, Yaszemski MJ, Jenkins RB, Bolander ME, Sarkar G. Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells. Anal Biochem. 2007 Jun 15; 365(2):215-21. Epub 2007 Mar 24.
    View PubMed
  25. Mandal D, Srivastava A, Mahlum E, Desai D, Maran A, Yaszemski M, Jalal SM, Gitelis S, Bertoni F, Damron T, Irwin R, O'Connor M, Schwartz H, Bolander ME, Sarkar G. Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene. 2007 Jan 15; 386(1-2):131-8. Epub 2006 Sep 20
    View PubMed
  26. Shogren KL, Turner RT, Yaszemski MJ, Maran A. Double-stranded RNA-dependent protein kinase is involved in 2-methoxyestradiol-mediated cell death of osteosarcoma cells. J Bone Miner Res. 2007 Jan; 22(1):29-36.
    View PubMed
  27. Maran A, Gorny G, Oursler MJ, Zhang M, Shogren KL, Yaszemski MJ, Turner RT. 2-methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts. J Cell Biochem. 2006 Oct 1; 99(2):425-34.
    View PubMed
  28. Maran A, Shogren K, Zhang M, Yaszemski MJ, Hefferan TE, Spelsberg TC, Kloosterboer HJ, Turner RT. Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone. Bone. 2006 Sep; 39(3):523-9. Epub 2006 May 16.
    View PubMed
  29. Kennedy AM, Shogren KL, Zhang M, Turner RT, Spelsberg TC, Maran A. 17beta-estradiol-dependent activation of signal transducer and activator of transcription-1 in human fetal osteoblasts is dependent on Src kinase activity. Endocrinology. 2005 Jan; 146(1):201-7. Epub 2004 Oct 07.
    View PubMed
  30. Maran A, Zhang M, Kennedy AM, Sibonga JD, Rickard DJ, Spelsberg TC, Turner RT. 2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells. Bone. 2002 Feb; 30(2):393-8.
    View PubMed
  31. Turner RT, Bolander ME, Sarkar G, An KN, Maran A, Ritman EL. An integrated approach to assess structure-to-function relationships in the skeleton. J Musculoskelet Neuronal Interact. 2001 Sep; 2(1):3-8.
    View PubMed
  32. Maran A, Zhang M, Spelsberg TC, Turner RT. The dose-response effects of ethanol on the human fetal osteoblastic cell line. J Bone Miner Res. 2001 Feb; 16(2):270-6.
    View PubMed
  33. Turner RT, Maran A, Lotinun S, Hefferan T, Evans GL, Zhang M, Sibonga JD. Animal models for osteoporosis. Rev Endocr Metab Disord. 2001 Jan; 2(1):117-27.
    View PubMed
  34. Turner RT, Kidder LS, Zhang M, Harris SA, Westerlind KC, Maran A, Wronski TJ. Estrogen has rapid tissue-specific effects on rat bone. J Appl Physiol (1985). 1999 Jun; 86(6):1950-8.
    View PubMed
  35. Turner RT, Evans GL, Zhang M, Maran A, Sibonga JD. Is resveratrol an estrogen agonist in growing rats? Endocrinology. 1999 Jan; 140(1):50-4.
    View PubMed